NWLC Reacts to Supreme Court Ruling on Alliance for Hippocratic Medicine v. FDA

Washington, DC — June 13, 2024 — Today, the Supreme Court ruled that the Alliance for Hippocratic Medicine doesn’t have standing to challenge the FDA’s approval of mifepristone, leaving access to the medication unchanged. 

In response, Fatima Goss Graves, president and CEO of the National Women’s Law Center (NWLC) issued the following statement:

“We are relieved for patients and providers that mifepristone will remain available. However, we are acutely aware of how close we came to losing access to an FDA-approved medication due to a fringe effort to invalidate scientific evidence and to further decimate abortion access nationwide. Our democratic systems are in jeopardy when extremists can drive meritless cases filled with inaccuracies and we come this close to losing a drug critical for abortion and miscarriage care, in efforts driven by misinformation through our federal court system, cherry picking judges who will do their bidding.

We also know that this may be a temporary reprieve, as other opponents of abortion are waiting in the wings to bring another challenge to mifepristone. We will never stop fighting for what is right and for a future where we, not the courts or anti-abortion extremists, control our own bodies, lives, and futures.”